Repligen Announces Agreement to Acquire ARTeSYN Biosolutions

ARTESYN Biosolutions Revenue Sources R REPLIGEN 6 BioProcess Systems & Flow Paths ~50% TFF Filtration Systems Chromatography Systems Buffer/Media Prep Systems 6. DOWNSTREAM FILTRATION AE-403 TE-401 AE-404 0 DOWNSTREAM CHROMATOGRAPHY Over Molded Tubing Sets from EMT DOWNSTREAM FINISH FILLING Components and Consumables ~50% Single-Use Flow Paths Valves, Valve Liners, Flow Path Exoskeletons Total Projected Revenue ~$30M in 2020 - ARTeSYN Biosolutions

View entire presentation